Log in

NASDAQ:GIVN - Given Imaging Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Given Imaging Ltd (Given) develops, manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. It is engaged in capsule endoscopy, which is an approach to visual examination of the gastrointestinal tract through the use of a miniaturized video camera contained in an ingestible disposable capsule. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:GIVN
CUSIPN/A
WebN/A
Phone+972-4-9097777

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive GIVN News and Ratings via Email

Sign-up to receive the latest news and ratings for GIVN and its competitors with MarketBeat's FREE daily newsletter.


Given Imaging (NASDAQ:GIVN) Frequently Asked Questions

What is Given Imaging's stock symbol?

Given Imaging trades on the NASDAQ under the ticker symbol "GIVN."

Has Given Imaging been receiving favorable news coverage?

Media stories about GIVN stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Given Imaging earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned press coverage about the healthcare company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Given Imaging.

What other stocks do shareholders of Given Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Given Imaging investors own include Cray (CRAY), Mazor Robotics (MZOR), Snap (SNAP), Teva Pharmaceutical Industries (TEVA), AudioCodes (AUDC), Activision Blizzard (ATVI), Advanced Micro Devices (AMD), Allot Communications (ALLT), American Airlines Group (AAL) and Altaba (AABA).

Who are Given Imaging's key executives?

Given Imaging's management team includes the folowing people:
  • Israel Makov, Chairman of the Board (Age 76)
  • Nachum Shamir, President, Chief Executive Officer, Director (Age 62)
  • Yuval Yanai, Chief Financial Officer (Age 64)
  • Skip Baldino, President, Americas (Age 53)
  • Thomas Pracht, President, EMEA (Age 56)
  • Kazem Samandari, President, Asia Pacific/Japan (Age 62)
  • Thomas Looby, Senior Vice President, Chief Marketing Officer (Age 44)
  • Ido Warshavski, Senior Vice President, General Counsel, Corporate Secretary (Age 44)
  • Keith A. Chrzanowski, Senior Vice President - Global Human Resources (Age 52)
  • Ori J Braun, Senior Vice President - Business Development (Age 57)

How can I contact Given Imaging?

Given Imaging's mailing address is Hermon Building, New Industrial Park, YOKNEAM, 2066724, Israel. The healthcare company can be reached via phone at +972-4-9097777.


MarketBeat Community Rating for Given Imaging (NASDAQ GIVN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Given Imaging and other stocks. Vote "Outperform" if you believe GIVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GIVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel